ACON

Aclarion, Inc. Common Stock

1.94

USD

-0.01

-0.36%

Nov 02, 11:51 UTC -5

Open

Aclarion, Inc. Common Stock (ACON) Earnings

ACON Earnings Reports

Positive Surprise Ratio

ACON beat 7 of 14 last estimates.

50%

Next Report

Date of Next Report

Estimate for Q-- -- (Revenue/ EPS)

Implied change from Q2 26 (Revenue/ EPS)

Implied change from Q-- -- (Revenue/ EPS)

Aclarion, Inc. Common Stock earnings per share and revenue

On Aug 06, 2026, ACON reported earnings of -1.12 USD per share (EPS) for Q2 26, missing the estimate of -1.07 USD, resulting in a -4.58% surprise. Revenue reached 25.21 thousand, compared to an expected 30.60 thousand, with a -17.61% difference. The market reacted with a -0.42% price change (close before vs. close after earnings).

Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Labcorp Holdings Inc.

Report Date

Oct 28, 2026 For Q3 26

Estimate

$4.79

Actual

$4.78

Surprise

-0.31%

Icon Plc

Report Date

Oct 27, 2026 For Q3 26

Estimate

$2.65

Actual

$2.66

Surprise

+0.27%

BrightSpring Health Services, Inc. Common Stock

Report Date

Oct 30, 2026 For Q3 26

Estimate

$0.48

Actual

$0.54

Surprise

+12.20%

Avantor, Inc.

Report Date

Oct 28, 2026 For Q3 26

Estimate

$0.21

Actual

$0.22

Surprise

+3.92%

Bausch + Lomb Corporation

Report Date

Oct 28, 2026 For Q3 26

Estimate

$0.22

Actual

$0.34

Surprise

+53.43%

CareDx, Inc.

Report Date

Oct 29, 2026 For Q3 26

Estimate

$0.25

Actual

$0.70

Surprise

+178.44%

Organon & Co.

Report Date

Oct 30, 2026 For Q3 26

Estimate

$0.94

Actual

$0.94

Surprise

-0.73%

Pediatrix Medical Group, Inc.

Report Date

Oct 29, 2026 For Q3 26

Estimate

$0.66

Actual

$0.72

Surprise

+7.61%

Establishment Labs Holdings Inc.

Report Date

Oct 29, 2026 For Q3 26

Estimate

-$0.26

Actual

-$0.31

Surprise

-18.41%

Teladoc Health, Inc.

Report Date

Oct 28, 2026 For Q3 26

Estimate

-$0.21

Actual

-$0.15

Surprise

+29.35%

FAQ

What were Aclarion, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Aclarion, Inc. Common Stock reported EPS of -$1.12, missing estimates by -4.58%, and revenue of $25.21K, -17.61% below expectations.

How did the market react to Aclarion, Inc. Common Stock's Q2 2026 earnings?

The stock price moved down -0.42%, changed from $2.36 before the earnings release to $2.35 the day after.

When is Aclarion, Inc. Common Stock expected to report next?

The next earning report is scheduled for --.

What are the forecasts for Aclarion, Inc. Common Stock's next earnings report?

Based on -- analysts, Aclarion, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.